Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Hypoxia has been recognised as an important tumoral feature related to resistance to radiotherapy since 1933. Recent advances in biological research have revealed important aspects on the cellular response to hypoxic stimuli and on the role of hypoxia pathways in the metabolism, growth and progression of cancer. The hypoxia-inducible factors (HIF-1a and HIF-2a) have been identified as key proteins that directly respond to hypoxic stress. Following hypoxia, stabilisation and nuclear binding of HIFs triggers the expression of a variety of genes related to erythropoiesis, glycolysis and angiogenesis. This review reports on and discusses the biology of the hypoxia pathways, the studies performed on the expression of HIFs in human cancer and the implications of hypoxia pathways in cancer therapy.

Type

Journal article

Journal

Anticancer Res

Publication Date

11/2001

Volume

21

Pages

4317 - 4324

Keywords

Animals, Basic Helix-Loop-Helix Transcription Factors, Cell Hypoxia, Humans, Hypoxia-Inducible Factor 1, alpha Subunit, Neoplasms, Signal Transduction, Trans-Activators, Transcription Factors